Milyen anyagokból készül a pofalemez (Jaw Dies)?Mik a …
Milyen anyagokból készül a pofalemez (Jaw Dies)?Mik a jellemzőik? A pofalemezek (Jaw Dies) a pofatörő állomás fő részének fontos részét képezik, és egyben a fő sérülékeny részét is képezik, mivel a pofalemezek (Jaw Dies) egy olyan rész, amely közvetlenül érintkezik az anyaggal, amikor a pofatörő. állomás működik.A törőanyagok folyamata …
Functional and morphologic outcomes of CAD/CAM-assisted …
Introduction: Mandibular reconstruction using fibula free flap has been improved in the last decade with computer-aided design and computer-aided manufacturing (CAD/CAM) but any functional and aesthetic evaluation of their reattempts has been realized. Aim of this retrospective study is to compare functional and morphologic outcomes after mandibular …
Abstract P1-14-03: ABRAZO: Exposure-efficacy and -safety …
Abstract. Background: Talazoparib (TALA) is a dual-mechanism poly (ADP-ribose) polymerase (PARP) inhibitor that traps PARP on DNA. Efficacy results of this phase 2 trial were previously presented (Turner et al, ASCO 2017, abstract 1007). This study included sparse pharmacokinetic (PK) sampling for patients through cycle 4 of therapy. …
Myositis ossificans circumscripta after surgery and …
Abstract. Background: Myositis ossificans circumscripta is a self-limiting, benign, ossifying lesion that can affect any type of soft tissue. It is most commonly found in muscles as a solitary lesion. A history of recent trauma …
Laser interstitial thermotherapy application for breast …
Laser Interstitial ThermoTherapy (LITT) is an option for the ablation of targeted nodules. This review evaluated the scientific publications investigating the LITT approach in malignant and benign breast disease. Three preclinical studies and eight clinical studies (2 studies including fibroadenomas and 6 studies including breast cancers) were ...
Komplett kőaprító
komplett kőaprítók. Kőaprító, Kőaprító Szállítók és a kőmaró áttörik a hagyományos rögzített zúzóberendezések kényszerét és magas szállítási költségeit. A beépített beállítás könnyen karbantartható és telepíthető, ami a mobil törőberendezés hosszú élettartamát és nagyobb hatékonyságát biztosítja.
Home hospitalization for palliative cancer care: factors
Background: Home hospitalization at the end of life can sometimes be perturbed by unplanned hospital admissions (UHAs, defined as any admission that is not part of a preplanned care procedure), which increase the likelihood of death in hospital. The objectives were to describe the occurrence and causes of UHAs in cancer patients …
Prognostic and predictive factors for angiosarcoma patients …
Retrospectively registered on EudraCT N° 2009-017020-59 and NCT01303497 (February 24, 2011).
BioPro-RCMI-1505 trial: multicenter study evaluating the use …
Background: Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity. Recently the contribution of "spacers" positioned in the septum between the …
A Multicenter Phase 2 study of Hypofractionated …
Electronic address: [email protected]. 2 Institut de Cancérologie de Lorraine-Alexis Vautrin, Nancy, France. 3 Centre Oscar Lambret, Academic Department of Radiation Oncology, University Lille II, Lille, France. 4 La Pitié Salpêtrière Charles Foix,UPMC, Paris, France. 5 Centre Leon Berard, Department of Radiation Oncology, …
Survival, safety, and prognostic factors for outcome with
Background: Randomized trials have shown a survival benefit for regorafenib over placebo in patients with metastatic colorectal cancer (mCRC) that progressed after standard therapies. We evaluated survival and safety outcomes in patients treated with regorafenib in a real-life setting. Methods: REBECCA is a cohort study nested within a …
Stereotactic Body Radiation Therapy for the Management of
This study aimed to describe patient characteristics, treatment efficacy, and safety in patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiation therapy (SBRT). We retrospectively analyzed data of 318 patients with 375 HCC treated between June 2007 and December 2018. Effic …
Usefulness of Stereotactic Body Radiation Therapy for …
Purpose: This study aimed to describe our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the management of adrenal gland metastases from multiple primary cancers.Materials and Methods: We retrospectively reviewed 31 patients who underwent SBRT as treatment for 33 adrenal gland lesions in …
Radiotherapy for penile cancers
Electronic address: [email protected]. 2 Département d'oncologie radiothérapie, institut de cancérologie de Lorraine centre Alexis-Vautrin, 6, avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. 3 Département d'oncologie radiothérapie, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06000 Nice, France. 4 Département de ...
[Radiotherapy treatment planning of prostate cancer using …
2 Unité de physique médicale, centre Oscar-Lambret, 3, rue Combemale, 59020 Lille, France; Unité de physique médicale, institut Curie, 35, rue Dailly, 92210 Saint-Cloud, France. 3 Department of radiation oncology, Comprehensive Cancer Center, Helsinki university central hospital, 00029 Helsinki, Finlande.
Successful administration of mitotane (O, p'-DDD) in …
1 Pharmacy Department, 56105Oscar Lambret Center, Lille, France. 2 Department of Pediatric Oncology, 56105Oscar Lambret Center, Lille, France. PMID: 35098802 DOI: 10.1177/107895 Abstract Introduction ...
Outcome of Patients with Platelet-Derived Growth Factor …
Abstract. Purpose: Platelet-derived growth factor receptor-alpha (PDGFRA) mutations are found in approximately 5% to 7% of advanced gastrointestinal stromal tumors (GIST). We sought to extensively assess the activity of imatinib in this subgroup.Experimental Design: We conducted an international survey among GIST …
Surgical versus non-surgical approach in primary desmoid-type
15 Medical Oncology Department, Centre Oscar Lambret, Lille, France. 16 Department of Medical Oncology and Hematology, Hôpitaux Civils Universitaires Strasbourg, Strasbourg, France. 17 Department of Pathology, Institut Bergonié, Bordeaux, France.
Multivariate analysis of risk factors for wound infection in
1 General Oncology Department, Centre Oscar Lambret, 3, rue F Combemale 59020 Lille, France; Hygiene Unit, Centre Oscar Lambret, Lille, France. [email protected]; PMID: 15743692 DOI: 10.1016/j.oraloncology.2004.08.011 Abstract The goal of this prospective study was to determine risk factors for wound infections (WI) for patients with head ...
Preoperative chemoradiation with paclitaxel-carboplatin or …
19 Department of Gastrointestinal Oncology, Centre Oscar Lambret, Lille, France. [email protected]. PMID: 27194176 PMCID: PMC4872363 DOI: 10.1186/s12885-016-2335-9 Abstract Background: Often curative treatment for locally advanced resectable esophageal or gastro-esophageal junctional cancer consists of …
A real-world study of ART in France (REOLA) comparing a
17 Hôpital Jeanne de Flandre, CHRU Lille, 2 Avenue Oscar Lambret, 59037 Lille. 18 Hôpital Jean Verdier, Centre Hospitalier Universitaire Paris Seine-Saint-Denis, Avenue du 14 Juillet, 93140 Bondy. 19 Centre Aliénor d'Aquitaine, Groupe Hospitalier Pellegrin, CENTRE HOSPITALIER UNIVERSITAIRE Bordeaux, 12 Place Amélie Raba-Léon, …
Localized Myxofibrosarcomas: Roles of Surgical …
Electronic address: [email protected]. 20 Department of Surgery, Curie Institute, Paris, France. PMID: 30191871 DOI: 10.1016/j.ijrobp.2018.05.055 Abstract Purpose: The objective of this study was to describe the outcome and prognostic factors for adults treated for localized myxofibrosarcoma. Methods and materials: We conducted a ...
Intensity-modulated Radiation Therapy With Simultaneous
Affiliations 1 Academic Department of Radiation Oncology, Centre Oscar Lambret, 3 rue Frédéric Combemale, F-59000, Lille, France. [email protected].; 2 CRIStAL UMR CNRS 9189, Université Lille, Avenue Carl Gauss, F-59650, Villeneuve-d'Ascq, France. [email protected].; 3 Academic Department of Radiation …
Mirvetuximab Soravtansine Monotherapy in Platinum …
Mirvetuximab Soravtansine (MIRV) is an investigational antibody drug conjugate designed to selectively kill cancer cells. The antibody (protein) part of MIRV targets tumors by delivering a cell-killing drug to the tumor cells carrying a tumor-associated protein called folate receptor alpha (FRα).
[Quality assessment of CAR T-cell activity: Recommendations …
14 CHU de Lille, université Lille, Inserm U1286, INFINITE, 2, avenue Oscar-Lambret, 59000 Lille, France. 15 Centre Henri-Becquerel, service d'hématologie, 1, rue d'Amiens, 76038 Rouen, France. PMID: 33187683 DOI: 10.1016/j.bulcan.2020.10.001 Abstract CAR T-cells are anti-cancer immunocellular therapy drugs that involve reprogramming the ...
Complication-related removal of totally implantable venous …
Affiliations 1 Department of Oncologic Surgery, Centre Régional de Lutte Contre le Cancer Oscar Lambret, 3 Rue Fréderic Combemale, BP 307, 59020 Lille Cedex, France. Electronic address: athanasios.kakkos@gmail. 2 Department of Oncologic Surgery, Centre Régional de Lutte Contre le Cancer Oscar Lambret, 3 Rue Fréderic Combemale, BP …
Keresés elektromos paradicsompasszírozó és húsdaráló
Találatok elektromos paradicsompasszírozó és húsdaráló keresésre ️ Fedezd fel széles termékkínálatunkat! ⚡️ Rendelj online az eMAG.hu-n!
Hypofractionated Stereotactic Radiotherapy for Patients with
Affiliations 1 Academic Department of Radiation Oncology, Centre Oscar Lambret, 3 rue Combemale, 59020, Lille cedex, France.; 2 Departement de radiotherapie, Institut de cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519, Vandœuvre-les-Nancy, France.; 3 Departement de radiotherapie, Centre François Baclesse, 3 Avenue …
The Management of Desmoid Tumors: A joint global …
N. Penel, Centre Oscar Lambret, Lille, France R. Pollock, The Ohio State University Comprehensive Cancer Center, Ohio, USA D. Pieper, Institute for research in operative medicine, Witten/Herdecke, Germany M. Portnoy, The Desmoid Tumor Research Foundation (DTRF)